Comparing two iron medicines for children with iron deficiency anemia
Compares iron polymaltose complex with ferrous sulfate in young children with iron deficiency anemia.
Key facts
- Who runs it
- Arooj Khan
- Where
- Pakistan1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients
- Status
- Recruiting
- People taking part
- 198 people, planned
- Started
- 10 Jan 2024
- Planned end
- 10 Jan 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Ferrous sulfate
- Iron Polymaltose Complex
- Record updated
- 19 December 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young children with iron deficiency anemia, a low blood count caused by too little iron. It compares two iron medicines taken by mouth.
- Age
- 6 Months to 5 Years
- Sex
- All
- Disease stage
- Iron deficiency anemia
- Earlier treatment
- Children who had a blood transfusion in the previous 4 weeks cannot join.
Main reasons for not taking part
- Congenital aplastic anemia or thalassemia, both inherited blood disorders
- Blood transfusion in the previous 4 weeks
- Malabsorption syndrome, where the gut does not take up food well, or diarrheal illness
- Bleeding in the gut, such as bloody vomit, black stools or bloody stools
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients having iron deficiency anemia
Who cannot take part
- Patients who were transfused in previous 4 weeks (will be determined on history)
- Children having mal-absorption syndrome and diarrheal illnesses. (will be determined on history and medical record)
- Gastrointestinal bleeding suggested by history of hematemesis (bloody vomit), melena (black colored stools) or bloody stools
- Patients diagnosed as congenital aplastic anemia or thalassemia (Determined from medical record)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to compare the efficacy of two iron preparation for the management of children presented with iron deficiency anemia. Ferrous sulphate and lron polymaltose (ferric form) are most commonly used preparations. Both drugs are easily available in market and are often recommended by pediatriclans. The efficacy, bioavail.tbilily, side effects and cost of these preparations vary. This study is designed to find out a drug with better efficacy that can be used for treatment of iron deficiency anemia in local population.
The 2 groups in the trial
- Group A (Ferrous sulphate)Existing treatment, for comparison
Group A will be given Ferrous sulphate in a dose of 6mg/kg/day of elemental iron once daily for 8 weeks orally in syrup form.
Treatment: Ferrous sulfate
- Group B (Iron Polymaltose complex)Existing treatment, for comparison
Group B will be given Iron Polymaltose complex in a dose of 6mg/kg/day of elemental iron once daily orally for 8 weeks.
Treatment: Iron Polymaltose Complex
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients With Iron Deficiency Anemia
- Plain-language title
- Comparing two iron medicines for children with iron deficiency anemiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 19 December 2024